Sunday - December 22, 2024

Formulation of (E)-2,4,6-Trimethoxystyryl-3-[(Carboxymethyl)amino]-4-Methoxybenzylsulphone With Enhanced Stability and Bioavailability

2024-12-03

ALEXANDRIA, Virginia, Dec. 3 -- TRAWS PHARMA, INC., Newtown, Pennsylvania has been assigned a patent (No. US 12156856 B2, initially filed June 6, 2022) developed by Manoj Maniar, Fremont, California, for "Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Formulation of (E)-2,4,6-Trimethoxystyryl-3-[(Carboxymethyl)amino]-4-Methoxybenzylsulphone With Enhanced Stability and Bioavailability

Information Request Form

Copyright Targeted News Service 2024